N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2
- 31 October 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (22) , 2557-2561
- https://doi.org/10.1016/s0960-894x(00)00510-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A 2Bioorganic & Medicinal Chemistry Letters, 2000
- Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitorBiochemical Journal, 1999
- Mechanism of Inhibition of LDL Phospholipase A2 by Monocyclic-β-lactams. Burst Kinetics and the Effect of StereochemistryBiochemistry, 1998
- Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Purines, pyrimidines and imidazoles. Part 67. Some N-substituted o-(2-hydroxyethyl)benzyl-purines, -pyrimidines and -imidazoles as aromatic acylonucleoside analoguesJournal of the Chemical Society, Perkin Transactions 1, 1993
- 11. Purines, pyrimidines, and glyoxalines. Part XI. Some oxazolidino- and thiazolidino-[2: 3-a]pyrimidines, and a synthesis of thymidineJournal of the Chemical Society, 1959